Oliver Dorigo
Chief · Stanford Health Care
Credentials: · · · · ·
History
- Present
- Present
Stanford Clinical Research Group for Gynecologic Cancer Trials · Stanford Health Care
- Present
Mary Lake Polan Gynecologic Oncology Research Laboratory · Stanford Health Care
- 2004–2005
UCLA Medical Center Obstetrics and Gynecology Fellowships (2005) CA
- 1995–1999
UCLA Medical Center Obstetrics and Gynecology Residency (1999) CA
- 1989–1992
Ludwig Maximillians University (1992) Germany
- 1985–1989
University of Heidelberg (1989) Germany
Research
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Nature · 2019 · 1,170 citations
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2019 · 840 citations
Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2018 · 505 citations
21 papers · 5 as a fellow
13 papers
- MR
9 papers · 5 as a fellow
8 papers
7 papers
7 papers
7 papers
7 papers
Clinical trials
- 2024–2027
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
Principal investigator · Recruiting · Phase 1
Stanford University
- 2021–2026
Principal investigator · Recruiting · Phase 1
BioEclipse Therapeutics
- 2017
Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN
Study chair · Terminated
Stanford University
- 2024–2029
Site PI · Recruiting · Phase 1, Phase 2
A2 Biotherapeutics Inc.